Document is current
Any future updates will be listed below
-
Authors
Garić, Dušan
Dumut, Daciana Catalina
Shah, Juhi
De Sanctis, Juan Bautista
Radzioch, Danuta https://orcid.org/0000-0002-1601-2757
-
Funding
Funding for this research was provided by:
Canadian Cystic Fibrosis Foundation (3645)
Ministry of Education, Youth and Sport, Czech Republic (869/V19)
- License Information
-
More Information
Article History
Received: 15 June 2019
Revised: 28 February 2020
Accepted: 15 April 2020
First Online: 11 May 2020
Compliance with ethical standards
:
: Dr. Danuta Radzioch is a scientific advisor and a shareholder in Laurent Pharmaceuticals Inc., which is currently running Phase II (APPLAUD) multicenter clinical trial aimed to assess the efficacy of fenretinide in patients with CF.
